These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1659055)

  • 1. Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure.
    Erturk M; Jennings R; Phillpotts RJ; Potter CW
    Vaccine; 1991 Sep; 9(9):668-74. PubMed ID: 1659055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation and characterization of FeLV ISCOMs.
    Akerblom L; Strömstedt K; Hoglund S; Osterhaus A; Morein B
    Vaccine; 1989 Apr; 7(2):142-6. PubMed ID: 2750272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
    Erturk M; Phillpotts RJ; Welch MJ; Jennings R
    Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.
    Ghazi HO; Erturk M; Stannard LM; Faulkner M; Potter CW; Jennings R
    Arch Virol; 1995; 140(6):1015-31. PubMed ID: 7611875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems.
    Hassan Y; Brewer JM; Alexander J; Jennings R
    Vaccine; 1996 Dec; 14(17-18):1581-9. PubMed ID: 9032885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus ISCOMs: biochemical characterization.
    Sundquist B; Lövgren K; Höglund S; Morein B
    Vaccine; 1988 Feb; 6(1):44-8. PubMed ID: 3354257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein variability in herpes simplex virus type 1 strains by radioimmunoprecipitation with monoclonal antibodies.
    al-Ahdal MN
    Microbios; 1993; 74(299):95-102. PubMed ID: 8395644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment.
    Mukhlis FA; Jennings R; Stephenson TJ; Quasim T; Potter CW
    Vaccine; 1986 Sep; 4(3):191-6. PubMed ID: 3020821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.
    Merza M; Söber J; Sundquist B; Toots I; Morein B
    Arch Virol; 1991; 120(3-4):219-31. PubMed ID: 1720302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.
    Erturk M; Hill TJ; Shimeld C; Jennings R
    Arch Virol; 1992; 125(1-4):87-101. PubMed ID: 1642562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations.
    Ertürk M; Jennings R; Hockley D; Potter CW
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2149-55. PubMed ID: 2769234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents.
    Jennings R; Erturk M
    J Med Virol; 1990 Jun; 31(2):98-108. PubMed ID: 2167352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine leukaemia virus ISCOMs: biochemical characterization.
    Merza MS; Linné T; Höglund S; Portetelle D; Burny A; Morein B
    Vaccine; 1989 Feb; 7(1):22-8. PubMed ID: 2541575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zwitterionic detergent solubilisation of HSV-1 surface antigens.
    Jennings R; Quasim T; Sharrard RM; Hockley D; Potter CW
    Arch Virol; 1988; 98(3-4):137-53. PubMed ID: 2831853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glycoprotein gII ISCOMs subunit vaccine for pseudorabies in pig.
    Tsuda T; Sugimura T; Murakami Y
    Vaccine; 1991 Sep; 9(9):648-52. PubMed ID: 1659053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a 30K glycoprotein of herpes simplex virus type 2.
    Qin KF; Yu QG; Gao Q; Wang MX; Jiang SZ
    J Gen Virol; 1992 Jul; 73 ( Pt 7)():1693-701. PubMed ID: 1321210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Envelope and membrane glycoproteins of Herpes simplex virus].
    Ramos-Kuri JM
    Rev Latinoam Microbiol; 1992; 34(1):23-31. PubMed ID: 1345300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR; Heath AW; Jennings R
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of herpes simplex virus type 1 glycoproteins: two-dimensional gel analysis using monoclonal antibodies.
    Palfreyman JW; Haarr L; Cross A; Hope RG; Marsden HS
    J Gen Virol; 1983 Apr; 64 (Pt 4)():873-86. PubMed ID: 6300307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.